CompuMed, Inc.
CMPD
$4.40
$0.051.15%
OTC PK
| 03/31/2012 | 12/31/2011 | 06/30/2011 | 03/31/2011 | ||
|---|---|---|---|---|---|
| Revenue | 1.42% | 1.76% | -2.90% | -9.98% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 1.42% | 1.76% | -2.90% | -9.98% | |
| Cost of Revenue | 3.88% | 19.41% | 11.60% | 9.57% | |
| Gross Profit | -0.92% | -11.40% | -12.73% | -22.97% | |
| SG&A Expenses | -13.88% | -41.95% | -23.20% | -9.94% | |
| Depreciation & Amortization | -41.38% | -34.48% | -13.79% | -3.33% | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -8.33% | -21.78% | -10.94% | -3.01% | |
| Operating Income | 53.26% | 93.85% | 54.88% | -50.82% | |
| Income Before Tax | 68.49% | 110.92% | 91.01% | -7.35% | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | 68.49% | 110.92% | 91.01% | -7.35% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | 68.49% | 110.92% | 91.01% | -7.35% | |
| EBIT | 53.26% | 93.85% | 54.88% | -50.82% | |
| EBITDA | 60.00% | 110.89% | 81.13% | -109.68% | |
| EPS Basic | 69.06% | 83.49% | 91.11% | -5.19% | |
| Normalized Basic EPS | 69.14% | 110.72% | 91.03% | -5.29% | |
| EPS Diluted | 69.06% | 83.49% | 91.11% | -5.19% | |
| Normalized Diluted EPS | 69.14% | 110.72% | 91.03% | -5.29% | |
| Average Basic Shares Outstanding | 1.98% | 1.98% | 0.71% | 2.03% | |
| Average Diluted Shares Outstanding | 1.98% | 1.98% | 0.71% | 2.03% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |